Vaccine Trials Archives - Maritime Shipping News

US’s NIH Still On The Lookout For COVID Vaccine Trial Volunteers

4 December 2020

The US National Institutes of Health is still looking for volunteers to participate in vaccine trials, Director Dr. Francis Collins said in an interview Wednesday with CNN’s Wolf Blitzer.

“We still do need people to take part in these trials,” Collins said.

Even though two vaccines are close to receiving emergency use authorization from the US Food and Drug Administration, four more are still in the works, he said.

Counting on volunteers

“And the more we have the better because the sooner we can...

https://mfame.guru/uss-nih-still-on-the-lookout-for-covid-vaccine-trial-volunteers/

First COVID Vaccine Likely To Be Approved By Mid December

21 November 2020

In a major development, Pfizer Inc (PFE.N) said that they will apply to U.S. health regulators on Friday for emergency use authorization (EUA) of its COVID-19 vaccine, the first such application in a major step toward providing protection against the new coronavirus, reports Reuters.

Backdrop

The application to the U.S. Food and Drug Administration (FDA) comes just days after Pfizer and German partner BioNTech SE 22UAy.DE (BNTX.O) reported final trial results that showed the vaccine was 95%...

https://mfame.guru/first-covid-vaccine-likely-to-be-approved-by-mid-december/

[Watch] Pfizer Vaccine To Reduce Transmission by 50%, 2021 Winter Normalcy

18 November 2020

According to a BBC report, BioNTech founder who is one of the creators of the Pfizer COVID Vaccine has said that the impact of a new Covid vaccine will kick in significantly over summer and life should be back to normal by next winter.

50% Reduction in Virus Transmission

Prof Ugur Sahin, BioNTech co-founder, also raised hopes the jab could halve transmission of the virus, resulting in a “dramatic reduction in cases”.

Last week, BioNTech and co-developers Pfizer said preliminary analysis showed...

https://mfame.guru/watch-pfizer-vaccine-to-reduce-transmission-by-50-2021-winter-normalcy/

First ‘Milestone’ COVID Vaccine 90% Effective

11 November 2020

A preliminary report of the first effective coronavirus vaccine can prevent more than 90% of people from getting Covid-19, says an article written by BBC Health and Science Correspondent, James Gallagher.

No Safety Concern

The developers – Pfizer and BioNTech – described it as a “great day for science and humanity”.

Their vaccine has been tested on 43,500 people in six countries and no safety concerns have been raised.

High Effectivity Paving the Way for EUA

The companies plan to apply for...

https://mfame.guru/first-milestone-covid-vaccine-90-effective/

90% Effective Oxford Vaccine, Yet To Confirm COVID19 Prevention Capacity

20 July 2020

Research published in Lancet proves evidence that Oxford Vaccine can create COVID antibodies and T-cell.
Vaccine effective in 90% people who took part in trials.
70% suffered from side effects of fever or headache.
Side effects can be treated by paracetamol
Immune response reaches peak in 14 days.
Researchers looking towards next level of phase trials to gather evidence on COVID19 prevention.

According to a BBC report written by BBC Health and Science Correspondent, James Gallagher, a...

https://mfame.guru/90-effective-oxford-vaccine-yet-to-confirm-covid19-prevention-capacity/

Don’t Fast Track Clinical Trials, COVID19 Vaccine Safety Test Crucial!

16 June 2020

As efforts to find an effective vaccine for SARS-CoV-2 ramp up, an immunologist warns that fast-tracking of clinical trials could be catastrophic, reports Medical News Today.

Share on PinterestA newly published commentary warns against the dangers of fast-tracking the clinical trials for finding a vaccine for SARS-CoV-2.

Coronavirus Vaccine Hope

Scientists around the globe are working to develop an effective vaccine for the novel coronavirus, SARS-CoV-2.

Until such a time, the world is reliant on...

https://mfame.guru/dont-fast-track-clinical-trials-covid19-vaccine-safety-test-crucial/